Immunoassay Systems: Global Strategic Business Report

Report
267 Pages
April 2024
Region: Global
Global Industry Analysts, Inc
ID: 338902

Global Immunoassay Systems Market to Reach $29.9 Billion by 2030

The global market for Immunoassay Systems estimated at US$22.1 Billion in the year 2022, is projected to reach a revised size of US$29.9 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2022-2030. Reagents & Kits, one of the segments analyzed in the report, is projected to record a 3.8% CAGR and reach US$19.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Analyzers / Instruments segment is readjusted to a revised 3.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $6 Billion, While China is Forecast to Grow at 6.6% CAGR

The Immunoassay Systems market in the U.S. is estimated at US$6 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$6.2 Billion by the year 2030 trailing a CAGR of 6.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1% and 4.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$4 Billion by the year 2030.

Select Competitors (Total 29 Featured) -

Abbott Laboratories
Beckman Coulter Inc.
bioMérieux SA
Bio-Rad Laboratories Inc.
DiaSorin S.p.A
Ortho-Clinical Diagnostics Inc.
Quidel Corporation
Roche Diagnostics
Siemens Healthineers
Sysmex Corporation
Tosoh Bioscience Inc.

What's New?

Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and Research Platform
Complimentary updates for one year

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
Immunoassay Systems: An Introductory Prelude
Recent Market Activity
Steady Growth Projected for World Immunoassay Systems Market
Expanding Applications Boost Market Prospects
Northbound Trajectory in Healthcare Spending Underpins Value Growth
Developed Regions - Primary Revenue Contributors
Fast Paced Growth Forecasts in Developing Regions
Expansion in Healthcare Infrastructure & Rising Healthcare Awareness Fuel Demand in Developing Regions
Immunoassay Systems - Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

Abbott Laboratories (USA)
Beckman Coulter, Inc. (USA)
bioMérieux SA (France)
Bio-Rad Laboratories Inc. (USA)
DiaSorin S.p.A (Italy)
Fujirebio, Inc. (Japan)
Ortho-Clinical Diagnostics, Inc. (USA)
Quidel Corporation (USA)
Roche Diagnostics (Switzerland)
Siemens Healthineers (USA)
Sysmex Corporation (Japan)
Tosoh Bioscience Inc. (USA)

3. MARKET TRENDS & DRIVERS

Bespoke Solutions Energize Market Growth
Multiplex Immunoassays Accelerate Overall Market Expansion
ELISA - Preferred Immunoassay Test in Research and Diagnostic Applications
Automation of ELISA - Enabling its Sustenance
Growing Popularity of Multiplexing Deters ELISA Market
Commoditization: A Key Issue Facing ELISA Product Manufacturers
Chemiluminescence Immunoassays Gain Prominence
Waning Demand for Radioimmunoassay Systems
Immunoassays Solidify their Role in Biomarker Detection
SERS - An Attractive Readout Strategy
Automated Immunoassay Systems - In Line with Automation Trend
Point-of-Care (POC) and Digital immunoassay (DIA) Systems Make Substantial Gains
Miniaturization Aids Roll Out of Sophisticated POC and DIA Systems
Ultra-Sensitive Platforms Set to Proliferate the Market
Infectious Disease Diagnosis - Primary Application Area
Increasing Incidence of Infectious Diseases - An Opportunity Indicator
Growing Significance in Cancer Care
Sustained Opportunities in Endocrine Testing Procedures
Diabetes Testing
Prenatal Testing
Vital Role in Blood Processing Applications
Blood Grouping and Typing
Food Sciences and Quality Control Offer Robust Growth Verticals
Growing Prominence of Immunoassays in New & Niche Application Verticals: A Review
Environmental Testing
Drugs of Abuse Testing (DAT)
Therapeutic Drug Monitoring (TDM)
Immune Diseases
Expanding Use Case in Biomedical Research Processes Amplifies Demand
Consolidation of Hospitals and Labs Triggers Robust Growth Opportunities
Rising Medical Needs of Aging Population - A Market Driver

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for Rapid Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 2: World Historic Review for Rapid Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 3: World 18-Year Perspective for Rapid Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
Table 4: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 5: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 6: World 18-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
Table 7: World Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 8: World Historic Review for Immunoassay Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 9: World 18-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2023 & 2030
Table 10: World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 11: World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 12: World 18-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
Table 13: World Recent Past, Current & Future Analysis for Analyzers / Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 14: World Historic Review for Analyzers / Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 15: World 18-Year Perspective for Analyzers / Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
Table 16: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 17: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 18: World 18-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
Table 19: World Recent Past, Current & Future Analysis for Enzyme Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 20: World Historic Review for Enzyme Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 21: World 18-Year Perspective for Enzyme Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
Table 22: World Recent Past, Current & Future Analysis for Radioimmuno Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 23: World Historic Review for Radioimmuno Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 24: World 18-Year Perspective for Radioimmuno Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
Table 25: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 26: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 27: World 18-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
Table 28: World Recent Past, Current & Future Analysis for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 29: World Historic Review for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 30: World 18-Year Perspective for Clinical Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
Table 31: World Recent Past, Current & Future Analysis for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 32: World Historic Review for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 33: World 18-Year Perspective for Blood Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
Table 34: World Recent Past, Current & Future Analysis for Pharmaceutical & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 35: World Historic Review for Pharmaceutical & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 36: World 18-Year Perspective for Pharmaceutical & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
Table 37: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 38: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 39: World 18-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
Table 40: World Immunoassay Systems Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030

III. MARKET ANALYSIS

UNITED STATES

Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)

CANADA

JAPAN

Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)

CHINA

Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)

EUROPE

Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)

FRANCE

Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)

GERMANY

Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)

ITALY

UNITED KINGDOM

Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)

SPAINRUSSIAREST OF EUROPE

ASIA-PACIFIC

Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)

AUSTRALIA

Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)

INDIA

Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)

SOUTH KOREAREST OF ASIA-PACIFIC

LATIN AMERICA

Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)

ARGENTINABRAZILMEXICOREST OF LATIN AMERICA

MIDDLE EAST

Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)

IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST

AFRICA

Immunoassay Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)

IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Abbott Laboratories
Beckman Coulter Inc.
bioMérieux SA
Bio-Rad Laboratories Inc.
DiaSorin S.p.A
Ortho-Clinical Diagnostics Inc.
Quidel Corporation
Roche Diagnostics
Siemens Healthineers
Sysmex Corporation
Tosoh Bioscience Inc.

Table Information

Report Attribute	Details
No. of Pages	267
Published	April 2024
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 22.1 Billion
Forecasted Market Value ( USD ) by 2030	$ 29.9 Billion
Compound Annual Growth Rate	3.9%
Regions Covered	Global

PURCHASE OPTIONS

Single User License PDF

1 - 10 User License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5462EUR$5,600USD£4,664GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€10379EUR$10,640USD£8,861GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€16387EUR$16,800USD£13,991GBP

Global Immunoassay Systems Market to Reach $29.9 Billion by 2030

The U.S. Market is Estimated at $6 Billion, While China is Forecast to Grow at 6.6% CAGR

Select Competitors (Total 29 Featured) -

What's New?

Table of Contents

Companies Mentioned (Partial List)

Table Information

Related Topics

Related Reports

Automated Immunoassay Analyzers: Global Strategic Business Report

Multiplex Detection Immunoassays - Global Strategic Business Report

Global Chemiluminescence Immunoassay Market by Product (Instrument, Consumable), Technology (Chemiluminescence Enzyme, Microparticle Chemiluminescence), Sample (Blood, Urine), Application (Infectious Disease, Oncology), End User - Forecast to 2028

Lipopolysaccharides Immunoassay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Chemiluminescence Immunoassay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)